03-Mar-2021

Wilson’s Disease Treatment Market at Splendid Growth of 652.9 Million USD By Technology, Future Opportunities and Challenges

Global Wilson’s disease Treatment Market

Wilson’s disease also referred as hepatolenticular degeneration and progressive lenticular degeneration, is a rare genetic disorder that causes copper poisoning in the body. It is so rare that it affects around 1 in 30,000 people worldwide. It is typically characterized by loss of function of the ATP7B copper-binding protein that leads to impaired copper transport and excretion, which results in accumulation of free copper in the bloodstream that results in damage of liver, brain, and other organs. Wilson’s disease is challenging to differentiate from other serious hepatic or neurologic conditions, due to which fewer patients are expected to be diagnosed than its actual prevalence. Wilson’s disease is characterized by the degree of accumulation of free copper in liver and the brain. Although there are no definite symptoms for Wilson’s disease, patients may suffer from abdominal pain, problems in coordination and abnormality in walking, dark rings in the iris, swelling, fatigue, tremor, or yellow skin and eyes.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/526

Wilson disease is suspected in the individual of age 3 – 60 years, whereas the chance of child inheriting autosomal recessive mutation from both the parent by gene mutation is 25% or one in four ratio.

The global Wilson’s disease treatment market was valued at US$ 392.0 million in 2016 and is expected to witness a robust CAGR of 6.0% during the forecast period (2017-2025).

Wilson’s Disease Treatment Market Value (US$ Million), 2017

Source: Coherent Market Insights 2017

Rampant advancements in technology allowing for early detection driving growth of the Wilson’s disease treatment market

Among regions, North America accounts for the market largest share in the global Wilson’s disease treatment market, followed by Europe. This is owing to rapid growth in geriatric population in these regions. Furthermore, Asia Pacific is expected witness the fastest growth in the global Wilson’s disease treatment market, increasing population in China and India. Moreover, increase in health expenditure on healthcare further are expected drive growth of Wilson’s disease treatment market in the region. The market is expected to show high growth rate in Asia Pacific region over the forecast period as Asia consist of 60% of the world’s current population and as Wilson’s disease is a hereditary disease the chance of expansion of this disease is more in Asia Pacific region. According to National Institute on Aging in 2010 it was estimated that 524 million people were aged 65 or older that is 8% of the world’s population and by 2050, which is expected to nearly triple the number to 1.5 billion, representing 16% of the world’s population. This above mentioned statistics is expected favor the growth of Wilson’s disease treatment market.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/526

Market Dynamics

Increase in awareness regarding Wilson’s disease is expected to fuel the Wilson’s disease treatment market in near future

Growing awareness related to Wilson’s disease is expected to drive growth of the global Wilson’s disease treatment market during the forecast period. There are various organizations and association working to create the awareness regarding Wilson’s disease for example, Wilson’s disease association is a volunteer organization striving to promote the well-being of the patients with Wilson’s disease where they offer the latest information about disease and its symptoms and treatment. Moreover Wilson’s disease association supports research and clinical investigation for Wilson’s disease.

Furthermore, manufacturers also significantly supports the Wilson’s disease awareness programs for example, in 2016, Valeant pharmaceutical announced company’s commitment to improve the lives of Wilson’s disease patients around the world, whereas Valeant has agreed to provide US$ 100,000 to fund enhanced patient awareness and research into the Wilson’s disease.

Difficulty in diagnosing and late realization of symptoms are expected to restrain growth of the global Wilson’s disease treatment market over the forecast period.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/wilsons-disease-treatment-market-to-surpass-us-6529-million-threshold-by-2025-with-north-america-positioned-as-growth-engine-295

Competitive Landscape

Major companies operating in the global Wilson’s disease treatment market are Valeant Pharmaceuticals International, Inc., Noblepharma Co., Ltd., Wilson Therapeutics AB, Kadmon Holdings, Inc., Merck & Co., Inc., VHB Life Science Ltd., Teva Pharmaceuticals USA, Inc. and Tsumura & Co.

Table of Contents

Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet By Different Segments
  - Coherent Attractive Investment Proposition and Total Addressable Market
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers, Restraints and Opportunities
  - Regulatory Scenario
  - Market Trends
  - PEST Analysis
Global Wilson’s Disease Treatment Market, By Treatment Type , 2016 – 2025 (US$ Million)
- Introduction
  - Market Share Analysis, 2017 and 2025 (%)
  - Y-O-Y Growth Analysis, 2016 – 2025
  - Segment Trends
- Medications
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2016 – 2025, (US$ Million)
    - D-Penicillamine
      - Introduction
      - Market Size and Forecast, and Y-O-Y Growth, 2016 – 2025, (US$ Million)
    - Trientine
    - Zinc
    - Tetrathiomolybdate
- Others
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2016 – 2025, (US$ Million)
Global Wilson’s Disease Treatment Market, By Distribution Channel, 2016 – 2025 (US$ Million)
- Introduction
  - Market Share Analysis, 2017 and 2025 (%)
  - Y-O-Y Growth Analysis, 2016 – 2025
  - Segment Trends
- Hospitals Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2016 – 2025, (US$ Million)
- Government Distribution Channel
- Retail and e-Pharmacies
Global Wilson’s Disease Treatment Market, By Geography, 2016 – 2025 (US$ Million)
- Introduction
  - Market Share Analysis, By Geography, 2017 and 2025 (%)
  - Y-O-Y Growth Analysis, 2016 – 2025
  - Regional Trends
- North America
  - Introduction
  - Market Share Analysis, By Country, 2017 and 2025 (%)
  - Country Trends
  - Market Size and Forecast, and Y-o-Y Growth, 2016-2025, (USD Million)
    - U.S.
      - Market Size and Forecast, By Treatment Type , 2016 – 2025 (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2025 (US$ Million)
    - Canada
- Europe
  - Introduction
  - Market Share Analysis, By Country, 2017 and 2025 (%)
  - Country Trends
  - Market Size and Forecast, and Y-o-Y Growth, 2016-2025, (USD Million)
    - U.K.
      - Market Size and Forecast, By Treatment Type , 2016 – 2025 (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2025 (US$ Million)
    - Germany
    - Italy
    - France
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Share Analysis, By Country, 2017 and 2025 (%)
  - Country Trends
  - Market Size and Forecast, and Y-o-Y Growth, 2016-2025, (USD Million)
    - China
      - Market Size and Forecast, By Treatment Type , 2016 – 2025 (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2025 (US$ Million)
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Share Analysis, By Country, 2017 and 2025 (%)
  - Country Trends
  - Market Size and Forecast, and Y-o-Y Growth, 2016-2025, (USD Million)
    - Brazil
      - Market Size and Forecast, By Treatment Type , 2016 – 2025 (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2025 (US$ Million)
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Share Analysis, By Country, 2017 and 2025 (%)
  - Country Trends
  - Market Size and Forecast, and Y-o-Y Growth, 2016-2025, (USD Million)
    - GCC
      - Market Size and Forecast, By Treatment Type , 2016 – 2025 (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2025 (US$ Million)
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Share Analysis, By Country, 2017 and 2025 (%)
  - Country Trends
  - Market Size and Forecast, and Y-o-Y Growth, 2016-2025, (USD Million)
    - North Africa
      - Market Size and Forecast, By Treatment Type , 2016 – 2025 (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2025 (US$ Million)
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Valeant Pharmaceuticals International. Inc.
    - Company Highlights
    - Key Developments
    - Product Portfolio
    - Market Presence
    - Investment Raised
    - Marketing and Promotional Activities
    - Strategic Presence
  - Tsumura & Co
  - Merck & Co.
  - VHB Life Science Inc.
  - Teva Pharmaceuticals USA, Inc.
  - Wilson’s Therapeutics AB
  - Noble Pharma Co., Ltd
  - Kadmon Holding, Inc.
Section
- Research Methodology
- About us and Services

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 03-Mar-2021